FBITX | TLLHX | FBITX / TLLHX | |
Total Expense Ratio | 0.46 | 0.20 | 230% |
Annual Report Gross Expense Ratio | 0.46 | 0.28 | 164% |
Fund Existence | 11 years | 10 years | - |
Gain YTD | 6.850 | 7.636 | 90% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 100000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 36.5B | 7.71B | 473% |
Annual Yield % from dividends | 1.21 | 1.98 | 61% |
Returns for 1 year | 10.15 | 13.13 | 77% |
Returns for 3 years | 39.14 | 50.73 | 77% |
Returns for 5 years | 47.71 | 74.67 | 64% |
Returns for 10 years | 73.84 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
THISX | 77.36 | -0.37 | -0.48% |
T. Rowe Price Health Sciences I | |||
WLCAX | 14.17 | -0.11 | -0.77% |
Allspring Large Company Value A | |||
FBSRX | 35.23 | -0.48 | -1.34% |
Franklin Mutual U.S. Mid Cap Value R | |||
RLITX | 15.57 | -0.23 | -1.46% |
Lazard International Strategic Eq R6 | |||
ISTAX | 23.86 | -0.47 | -1.93% |
ICON Equity Investor |